DXC014

· Hangzhou DAC Biotechnology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DXC014, covering 2026-04-24 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study of DXC014 in Patients With Advanced Solid Tumors. [Phase 1]